Procurement Summary
Country: Italy
Summary: Ca 27/2026 - Professional Collaboration Assignment under Vat Number as Part of Projects 1. "Phase i Study, Multicentre, Non-Randomized, Open-Label, Adaptive Single Dose, Increasing V...
Deadline: 19 Jun 2026
Posting Date: 06 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142769075
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
CA 27/2026 - Professional Collaboration Assignment under VAT number in the context of projects 1. "Phase I, multicenter, non-randomized, open-label, adaptive single-dose, growing study aimed at examining the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of RO7121932 after intravenous administration in patients with multiple sclerosis)"; 2. "Randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to teriflunomide in adult participants with relapsing forms of multiple sclerosis”; 3. “A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult part
Deadline: 06/19/2026 12:00 Publication: 05/06/2026
Documents
Tender Notice